Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Sequestosome-1 ZZ domain (p62 ZZ domain) is a zinc finger domain within the Sequestosome-1 (SQSTM1/p62) protein that specifically recognizes and binds type-1 and type-2 N-degrons, including N-terminal arginine (Nt-Arg), as part of the N-end rule pathway for targeted protein degradation. This domain is structurally and functionally homologous to the UBR box of classic N-recognins, but employs a distinct binding mode for substrate recognition. The p62 ZZ domain is essential for the aggregation of p62 and its cargo, facilitating their delivery to autophagosomes for lysosomal degradation, a process critical for cellular homeostasis and stress response. It also contributes to the regulation of mTORC1 signaling and may modulate p62's own function through intramolecular interactions with a regulatory linker sequence. Mutations in the ZZ domain and its neighboring regions have been implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis, highlighting its importance in protein quality control and cellular health. The domain acts as a multiprotein and RNA interaction hub, linking the ubiquitin-proteasome system with selective autophagy pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sequestosome-1 ZZ domain (p62 ZZ domain).